Postmenopausal hormone therapy and cardiovascular disease: An overview of main findings
Authors:
- Marianne CanonicoMCMarianne Canonico
- Céline StraczekCSCéline Straczek
- Emmanuel OgerEOEmmanuel Oger
- Geneviève Plu-BureauGPGeneviève Plu-Bureau
- Pierre-Yves ScarabinPSPierre-Yves Scarabin
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hormone replacement therapy in postmenopausal womenThe American Journal of Surgery, 2004
- The greatest threat to women's healthThe Lancet, 2003
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) studyAtherosclerosis, 2003
- Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trialThe Lancet, 2002
- A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis StudyBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Hormone Replacement Therapy and Incidence of Acute Myocardial InfarctionCirculation, 2000
- Assessment of the Risk for Venous Thromboembolism Among Users of Hormone Replacement TherapyDrugs & Aging, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998